Prostaglandin E2 selectively antagonizes prostaglandin F 2α-stimulated T-cell factor/β-catenin signaling pathway by the FPB prostanoid receptor

Journal of Biological Chemistry

Volumn 279, Issue 42, 2004, Pages 43386-43391

  Fujino, Hiromichi ^a   Vielhauer, George A ^a   Regan, John W ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOLS; BIOCHEMISTRY; CELLS; MORPHOLOGY; PHOSPHATES;

CELL SIGNALING; EFFECTOR PATHWAYS; ISOFORMS; LIGANDS; SIGNALING PATHWAYS;

PROTEINS;

BETA CATENIN; INOSITOL PHOSPHATE; ISOPROTEIN; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTANOID RECEPTOR; T CELL FACTOR PROTEIN; CTNNB1 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; HYBRID PROTEIN; PROSTAGLANDIN F2ALPHA RECEPTOR; PROSTAGLANDIN RECEPTOR; PROTEIN SUBUNIT; TRANSACTIVATOR PROTEIN;

ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSFECTION; KIDNEY; METABOLISM; PHYSIOLOGY; REPORTER GENE;

BETA CATENIN; CELL LINE; CYTOSKELETAL PROTEINS; DINOPROST; DINOPROSTONE; GENES, REPORTER; HUMANS; KIDNEY; PROTEIN SUBUNITS; RECEPTORS, PROSTAGLANDIN; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSFECTION;

EID: 6344241868     PISSN: 00219258     EISSN: None     Source Type: Journal    
DOI: 10.1074/jbc.M408276200     Document Type: Article

References (23)

1. Pierce, K. L., Bailey, T. J., Hoyer, P. B., Gil, D. W., Woodward, D. F., and Regan, J. W. (1997) J. Biol. Chem. 272, 883-887
2. Graves, P. E., Pierce, K. L., Bailey, T. J., Rueda, B. R., Gil, D. W., Woodward, D. F., Yool, A. J., Hoyer, P. B., and Regan, J. W. (1995) Endocrinology 136, 3430-3436
3. Pierce, K. L., Fujino, H., Srinivasan, D., and Regan, J. W. (1999) J. Biol. Chem. 274, 35944-35949
4. Fujino, H., Pierce, K. L., Srinivasan, D., Protzman, C. E., Krauss, A. H., Woodward, D. F., and Regan, J. W. (2000) J. Biol. Chem. 275, 29907-29914
5. Fujino, H., and Regan, J. W. (2001) J. Biol. Chem. 276, 12489-12492
6. Fujino, H., Srinivasan, D., and Regan, J. W. (2002) J. Biol. Chem. 277, 48786-48795
7. Srivastava, S., Verma, M., and Henson, D. E. (2001) Clin. Cancer Res. 7, 1118-1126
8. Fujino, H., and Regan, J. W. (2003) Eur. J. Pharmacol. 465, 39-41
9. Oka, M., Inaba, A., Uchiyama, T., Hazama, S., Shimoda, K., Suzuki, M., and Suzuki, T. (1994) Am. J. Surg. 167, 264-267
10. Pugh, S., and Thomas, G. (1994) Gut 35, 675-678
11. Marnett, L. J., and DuBois, R. N. (2002) Annu. Rev. Pharmacol. Toxicol. 42, 55-80
12. Sonoshita, M., Takaku, K., Sasaki, N., Sugimoto, Y., Ushikubi, F., Narumiya, S., Oshima, M., and Taketo, M. M. (2001) Nat. Med. 7, 1048-1051
13. Fujino, H., and Regan, J. W. (2003) Trends Pharmacol. Sci. 24, 335-340
14. Fujino, H., Srinivasan, D., Pierce, K. L., and Regan, J. W. (2000) Mol. Pharmacol. 57, 353-358
15. Regan, J. W. (2003) Life Sci. 74, 143-153
16. Kobayashi, T., and Narumiya, S. (2002) Prostaglandins Other Lipid Mediat. 68-69, 567-573
17. Breyer, R. M., Bagdassarian, C. K., Myers, S. A., and Breyer, M. D. (2001) Annu. Rev. Pharmacol. Toxicol. 41, 661-690
18. Abramovitz, M., Boie, Y., Nguyen, T., Rushmore, T. H., Bayne, M. A., Metters, K. M., Slipetz, D. M., and Grygorczyk, R. (1994) J. Biol. Chem. 269, 2632-2636
19. Kenakin, T. (1995) Trends Pharmacol. Sci. 16, 232-238
20. Fujino, H., West, K. A., and Regan, J. W. (2002) J. Biol. Chem. 277, 2614-2619
21. Kiriyama, M., Ushikubi, F., Kobayashi, T., Hirata, M., Sugimoto, Y., and Narumiya, S. (1997) Br. J. Pharmacol 122, 217-224
22. Mariadason, J. M., Bordonaro, M., Aslaro, F., Shi, L., Kuraguchi, M., Velcich, A., and Augenlicht, L. H. (2001) Cancer Res. 61, 3465-3471
23. Brabletz, T., Jung, A., Reu, S., Porzner, M., Hlubek, F., Kunz-Schughart, L.A., Knuechel, R., and Kirchner, T. (2001) Proc. Natl. Acad. Sci U. S. A. 98, 10356-10361